In two other studies, CXCL13 expression was associated with higher tumor grade (grades 2–3), positive nodes, ER-negative status, longer metastasis-free survival, and a stronger prognostic effect in HER2-positive breast cancer [49,82]. This evidence concerns the gene ERBB2 and breast carcinoma.